355 related articles for article (PubMed ID: 29990559)
1. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
[TBL] [Abstract][Full Text] [Related]
2. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
Xin XY; Ding JQ; Chen SD
J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606
[TBL] [Abstract][Full Text] [Related]
4. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
[TBL] [Abstract][Full Text] [Related]
5. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
[TBL] [Abstract][Full Text] [Related]
6. Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients.
Parra-Bonilla G; Arboleda G; Yunis J; Solano E; Pardo R; Arango G; Hedmont D; Arboleda H
Neurosci Lett; 2003 Oct; 349(3):159-62. PubMed ID: 12951193
[TBL] [Abstract][Full Text] [Related]
7. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
8. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M
Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330
[TBL] [Abstract][Full Text] [Related]
9. Association study of apolipoprotein E promoter polymorphism (-427 T/C) and Alzheimer's disease in a Tunisian population.
Achouri-Rassas A; Ben Ali N; Fray S; Kechaou M; Oudiaa Zakraoui N; Hadj-Fredj S; Cherif A; Anane N; Echebi S; Messaoud T; Belal S
Rev Neurol (Paris); 2016 Feb; 172(2):127-31. PubMed ID: 26563666
[TBL] [Abstract][Full Text] [Related]
10. Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer's disease: A meta-analysis.
Xiao H; Gao Y; Liu L; Li Y
EXCLI J; 2017; 16():921-938. PubMed ID: 28900374
[TBL] [Abstract][Full Text] [Related]
11. The complex interaction between APOE promoter and AD: an Italian case-control study.
Bizzarro A; Seripa D; Acciarri A; Matera MG; Pilotto A; Tiziano FD; Brahe C; Masullo C
Eur J Hum Genet; 2009 Jul; 17(7):938-45. PubMed ID: 19172988
[TBL] [Abstract][Full Text] [Related]
12. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population.
Lynch CA; Brazil J; Cullen B; Coakley D; Gill M; Lawlor BA; Hawi Z
Ir J Med Sci; 2008 Mar; 177(1):29-33. PubMed ID: 18057979
[TBL] [Abstract][Full Text] [Related]
14. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
[TBL] [Abstract][Full Text] [Related]
15. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.
Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F
Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
Jiang S; Yang W; Qiu Y; Chen HZ;
Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
[TBL] [Abstract][Full Text] [Related]
17. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.
Xue S; Jia L; Jia J
Neurosci Lett; 2009 Nov; 465(2):181-3. PubMed ID: 19733630
[TBL] [Abstract][Full Text] [Related]
18. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease.
Belbin O; Dunn JL; Ling Y; Morgan L; Chappell S; Beaumont H; Warden D; Smith DA; Kalsheker N; Morgan K
Hum Mol Genet; 2007 Sep; 16(18):2199-208. PubMed ID: 17613540
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients.
Zill P; Engel R; Hampel H; Behrens S; Bürger K; Padberg F; Stübner S; Möller HJ; Ackenheil M; Bondy B
Eur Arch Psychiatry Clin Neurosci; 2001; 251(1):24-8. PubMed ID: 11315514
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.
Nicodemus KK; Stenger JE; Schmechel DE; Welsh-Bohmer KA; Saunders AM; Roses AD; Gilbert JR; Vance JM; Haines JL; Pericak-Vance MA; Martin ER
Neurogenetics; 2004 Dec; 5(4):201-8. PubMed ID: 15455263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
